SGLT-2 inhibitors may increase risk for amputation in type 2 diabetes

New users of sodium-glucose cotransporter 2 inhibitors may be more likely to undergo a lower extremity amputation when compared with users of other treatments for type 2 diabetes, such as sulfonylureas, metformin and thiazolidinediones, according to data published in JAMA Internal Medicine.”

Source: SGLT-2 inhibitors may increase risk for amputation in type 2 diabetes

About the Author

NutriScape Staff Writer

Write for NutriScape!